TET2: A cornerstone in normal and malignant hematopoiesis

Area of Science:

• Epigenetics and Genomics
• Hematology and Oncology

Background:

• Genome-wide DNA methylation is crucial for mammalian development, stem cell function, and oncogenesis.
• Ten-eleven translocation 2 (TET2) is a frequently mutated gene in hematological malignancies and clonal hematopoiesis.
• TET2 plays a vital role in blood homeostasis and hematopoietic transformation through DNA methylation regulation.

Purpose of the Study:

• To elucidate the multifaceted roles of TET2 in regulating DNA methylation and its impact on hematopoietic processes.
• To investigate the consequences of TET2 mutations in the context of hematological malignancies and stem cell function.

Main Methods:

• Review of existing studies on TET2 function, mutations, and associated biological processes.
• Analysis of single-cell genomics data to identify TET2-targeted genetic loci.
• Examination of the cooperative effects of TET2 mutations with other genetic alterations in hematopoietic transformation.

Main Results:

• TET2 oxidizes methylated cytosines, acting as an intermediate in DNA demethylation.
• TET2 interacts with histone modifiers, influencing gene expression and histone modifications.
• TET2 mutations disrupt DNA methylation at gene promoters and transcription factor binding sites, promoting leukemogenesis.
• TET2 mutations exhibit cooperative effects with other genetic lesions in signaling molecules, epigenetic modifiers, and spliceosome factors.

Conclusions:

• TET2 is a critical regulator of hematopoietic stem cell self-renewal, differentiation, genome stability, and inflammatory responses.
• Disruption of TET2 function fundamentally alters hematopoietic differentiation and contributes to leukemia development.
• Further research into TET2's role in stem cell and immune regulation is essential for understanding TET2-mutated hematological malignancies.